Aeruginosin 865 exhibits anti-inflammatory activity by inhibiting NF-κB nuclear translocation; it significantly suppresses TNF-α-induced IL-8 (EC₅₀ = 3.5 μg/mL) and ICAM-1 (EC₅₀ = 50.0 μg/mL) expression in human lung microvascular endothelial cells (HLMVECs) in a concentration-dependent manner; it shows no cytotoxicity in HeLa and HepG2 cells even at high concentrations, but demonstrates high-dose cytotoxicity in mouse fibrosarcoma cells while remaining non-cytotoxic in NIH/3T3 cells.